# KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)

> KLOW adds KPV, a tripeptide fragment derived from alpha-melanocyte-stimulating hormone, to the GLOW Blend's combination of BPC-157, TB-500, and GHK-Cu. KPV is studied in preclinical models mainly for anti-inflammatory activity in gut-related and dermatological contexts, reportedly without the pigmentation effects associated with full melanocortin-receptor activation. As the newest and most complex of the commonly referenced healing blends, KLOW has the least combined research behind it, with most information originating from informal research communities rather than published studies of the four-peptide combination. Each individual component has some preclinical basis, but interactions between all four have not been studied together. It is not approved for human use and should be treated as highly investigational.

- URL: https://www.lifeconverted.com/peptides/klow-blend
- Also known as: KLOW Stack, Quad Healing Blend
- Primary category: Healing Blends
- Effectiveness rank: #18 in Healing & Recovery; #10 in Anti-Inflammatory; #3 in Healing Blends
- Evidence level: Emerging research
- Route: Subcutaneous (Injected subcutaneously, generally into the abdomen; given the four combined actives, some research protocols recommend rotating sites and monitoring for irritation more closely than with simpler blends.)
- Dose range: 350-800 mcg
- Dose tiers: low 350 mcg; moderate 550 mcg; high 800 mcg
- Half-life: KPV is reported to have a short half-life on the order of minutes to about an hour in preclinical pharmacokinetic data, similar in range to GHK-Cu; combined with the longer-acting BPC-157 and TB-500, the blend's overall duration is uneven across its four components.
- Timing: Morning, or split AM/PM
- Cycle: 4 weeks on, 4 weeks off (A more conservative cycle length than the simpler blends is often recommended given the limited combined-use data for four actives together.)
- Storage: Refrigerate after reconstitution (2-8°C) and protect from light; practical use within about 2 weeks is commonly recommended given the number of sensitive components.

## Mechanism of action

BPC-157, TB-500, and GHK-Cu contribute the tissue-repair, angiogenic, and collagen-related mechanisms described for GLOW. KPV is proposed in preclinical studies to reduce inflammatory signaling, including through modulation of NF-κB pathway activity and reduced pro-inflammatory cytokine production, independent of classical melanocortin-receptor-driven pigmentation effects. Proponents describe the four-peptide combination as broadening anti-inflammatory coverage alongside structural and dermal repair, though this has not been verified through controlled research.

## Reported benefits

- Supports soft-tissue and connective-tissue repair
- Studied for anti-inflammatory activity in preclinical gut and skin models
- Associated with collagen and skin-quality support
- General recovery and inflammation-related research interest

## Reported side effects

- Injection site irritation
- Mild nausea
- Lethargy
- Headache (uncommon)

## Common protocols

- Comprehensive Recovery Stack
- Gut & Joint Support
- Post-Injury Anti-Inflammatory Protocol

## Stacking notes

The most complex of the commonly referenced healing blends. Given limited combined data, some researchers prefer to trial the individual components, or the simpler BPC-157/TB-500 and GLOW combinations, before using the full four-peptide blend.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer